Largest Phase 0 Clinical Trials Program in the World
The Ivy Brain Tumor Center houses a specialized array of preclinical and clinical laboratories assembled with the singular objective to bring new therapies to brain tumor patients. With over 20,000 square feet of integrated wet and dry laboratory space specialized for pharmacodynamic- and pharmacokinetic-driven trials, our investigators work together to identify prospective new agents, devise first-in-class therapeutic combinations, and rapidly assess drug penetration and tumor responses from our clinical trials.
Distinguishing features of the Ivy Brain Tumor Center include a pharmacokinetics core dedicated solely to brain tissue analysis, a team of preclinical and clinical scientists assembled around brain tumor pharmacodynamics, pharmacometabolomics, and pharmacokinetics, and exclusive access to the nation’s highest-volume operative brain tumor program.
We have five scientific cores working together to discover new therapies for brain tumor patients through a broad portfolio of clinical trials.Learn More
Our laboratories are committed to accelerating drug discovery and precision medicine in neuro-oncology.Learn More
We go through rigorous processes to ensure our study protocols and results exceed industry standards and better serve the patients.Learn More
Our preclinical studies assess the efficacy and safety of novel drug cocktails that have never before been tested in brain tumor patients.Learn More
We are actively pursuing new partnerships with pharmaceutical and biotech companies to test first-in-human or first-in-class drugs.Learn More
Our studies open and close in as little as six months. Results of our studies have been published in various academic journals.Learn More